Sibiul Medical nr 4_2007.p65

4. Bayard Max, Holt Jim, Boroughs Eileen– Non–
alcoholic Fatty Liver Disease– Journal of the
American Family Psysician, vol.73,No.11–2006
5. Oliver F.W.James– Nonalcolic fatty liver disease –
Chapter 115 of Yamada Takada –Texbook and atlas
of gastroenterology –CD –2006
6. Balisteri F. William – Nonalcoholic Fatty Liver
Disease – Insights and Controversies; Medscape
Today CME
7. Huang MA, Greenson JK, Chao C, Anderson L,
Peterman D, Jacobson J, Emick D, Lok AS,
Conjeevaram HS– One–year intense nutritional
counseling results in histological improvement in
patients with non–alcoholic steatohepatitis: a pilot
study.–Am J Gastroenterol.May 2005; 100(5):1072–
81
8. Iobagiu Silviu –Steatohepatita non–alcoolica –
Esentialul in gastroenterology si hepatologie sub. red.
Pascu O.–Editura National, 2003
9. Dufour J–F, Oneta C, Gonvers J–J, et al– – A 2–years
multicenter randomized placebo–controlled study
testing UDCA in combination with vitamin E to treat
NASH
10. Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, Ronnet
G, Diehl AM. Metformin reverses fatty liver disease
in obese leptin–deficient mice. Nat Med 2000; 6: 998
11. Boelsterli UA, Bedonoucha M, Atzpodien EA.
Selectively upregulated PPATg1 gene expression in
diabetic KKAg mice is associated with severe hepatic
steatosis after treatment with antidiabetic
thiazolidinediones. Hepatology 2000; 32: 296A
12. Laurin J, Lindor KD, Cruppen JS, et al.
Ursodeoxycholic acid or clofibrate in the treatment
of non–alcoholic–induced steatohepatitis: a pilot
study. Hepatology 1996; 23: 1464.
13. Rallidis LS, Drakoulis CK, Parasi AS. Pravastatin in
patients with nonalcoholic steatohepatitis: results of
a pilot study. Atherosclerosis 2004;174:193–6.
14. Pasternak RC, Smith SC Jr, Bairey–Merz CN, Grundy
SM, Cleeman JI, Lenfant C, et al. ACC/AHA/NHLBI
Clinical Advisory on the use and safety of statins.
Stroke 2002;33:2337–41.
20 „Sibiul Medical“ Volum 19 Nr. 4/2007